Back to Top
New Products
-
Praluzatamab Vedotin Biosimilar - Research Grade$700.00 - $3,024.00 -
Praluzatamab Ravtansine Biosimilar - Research Grade$1,050.00 - $4,536.00
-
-
-
Laprituximab Emtansine Biosimilar - Research Grade$1,050.00 - $4,536.00
-
Ladiratuzumab Vedotin Biosimilar - Research Grade$700.00 - $3,024.00
-
Labetuzumab Govitecan Biosimilar - Research Grade$700.00 - $3,024.00
-
-
Iladatuzumab Vedotin Biosimilar - Research Grade$700.00 - $3,024.00
-
Glembatumumab Vedotin Biosimilar - Research Grade$700.00 - $3,024.00
-
-
Who Bought This Also Bought
